Article Text

Download PDFPDF
Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer
  1. J D McKay1,
  2. D Thompson2,
  3. F Lesueur3,
  4. K Stankov4,
  5. A Pastore4,
  6. C Watfah5,
  7. S Strolz5,
  8. G Riccabona5,
  9. R Moncayo5,
  10. G Romeo4,
  11. D E Goldgar2
  1. 1Menzies Center for Population Health Research, Hobart, Tasmania, Australia
  2. 2International Agency for Research on Cancer, Lyon, France
  3. 3Strangeways Research Laboratory, Cambridge, UK
  4. 4Genetica Medica, Bologna, Italy
  5. 5University of Innsbruck, Innsbruck, Austria
  1. Correspondence to:
 D E Goldgar
 Unit of Genetic Epidemiology, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69008 Lyon, France; goldgariarc.fr

Abstract

Background: Familial non-medullary thyroid cancer (fNMTC) is a complex genetic disorder that is more aggressive than its sporadic counterpart. Thus far, three genetic loci have been implicated in susceptibility to fNMTC by linkage analysis.

Methods: We used linkage analysis to test the significance of two of the known susceptibility loci for fNMTC, TCO on 19p13 and NMTC1 on 2q21 in 10 fNMTC families, nine of which present with cell oxyphilia, a rare histological phenotype associated with TCO. Furthermore, we used two-locus linkage analysis to examine the possibility that the TCO and NMTC1 loci interact to increase the risk of NMTC.

Results: The 10 families provided evidence for linkage at both TCO and NMTC, with LOD scores of 1.56 and 2.85, respectively. Two-locus linkage analysis, using a multiplicative risk model for the development of NMTC, achieved a maximum LOD of 3.92, with an LOD of 4.51 when assuming 70% of families were linked, indicating that the segregation in these families is consistent with an interaction model. Most of this evidence came from a large Tyrolean family that singularly achieved a two-locus LOD of 3.21.

Conclusions: These results provide further evidence that susceptibility genes for fNMTC exist at 19p13 and 2q21, and furthermore, raise the possibility that in a subset of fNMTC pedigrees, these loci interact resulting in significantly increased risk of NMTC for patients that carry both susceptibility loci.

  • interaction
  • linkage
  • thyroid cancer
  • fNMTC, familial non-medullary thyroid cancer
  • fvPTC, follicular variant of PTC
  • LOH, loss of heterozygosity
  • PTC, papillary thyroid cancer

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • This work was supported by grant QLG1-CT-2001-01646-“The RET Proto-Oncogene” from the EU, by an FIRB grant for PRIME “Progetto Integrato Malattie Ereditarie” from the Italian Ministry of Research, and by funds from the Almagem Foundation and the Carisbo Foundation (Bologna).

  • Conflict of interest: none declared.